Optimer Rides High After OPT-80 C. Diff Trial Success
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III data show antibiotic non-inferior to Vancocin; additional trial results due mid-2009 with an NDA filing by year’s end.